Uncategorized

Emerging Field Grant supports childhood cancer research

Emerging Field Grant supports childhood cancer research As part of the excellent=austria initiative, the Austrian Science Fund (FWF) is promoting innovative research collaborations in Austria through its Emerging Fields programme. Over the next five years, selected consortia will work to develop new, highly innovative research fields. Following a competitive international review process focusing on scientific […]

Emerging Field Grant supports childhood cancer research Read More »

Researchers decode cancer’s genetic control panel one DNA letter at a time

Researchers decode cancer’s genetic control panel one DNA letter at a time Scientists in Davide Seruggia’s group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI), together with collaborators at the Broad Institute of MIT and Harvard, have developed CRISPR-Millipede, a new CRISPR-based method that allows researchers to study regulatory DNA sequences at single-nucleotide

Researchers decode cancer’s genetic control panel one DNA letter at a time Read More »

Guiding Stem Cells Step by Step: New Tool Improves Models of Pediatric Cancer Development

Guiding Stem Cells Step by Step: New Tool Improves Models of Pediatric Cancer Development To study the molecular causes of pediatric cancer, scientists need to recreate complex developmental processes in the lab – an effort that often requires a great deal of trial and error. Scientists in the labs of Florian Halbritter and Davide Seruggia

Guiding Stem Cells Step by Step: New Tool Improves Models of Pediatric Cancer Development Read More »

St. Anna Research Kids: A project brings science into the hands of children with cancer

St. Anna Research Kids: A project brings science into the hands of children with cancer With the new hands-on initiative “St. Anna Research Kids,” scientists at St. Anna Children’s Cancer Research Institute have succeeded in bringing research directly into the daily lives of young patients at St. Anna Children’s Hospital. The project allows children and

St. Anna Research Kids: A project brings science into the hands of children with cancer Read More »

International Childhood Cancer Day: Research as the key to better survival rates

International Childhood Cancer Day: Research as the key to better survival rates (Vienna, February 15, 2026) Every year, around 400,000 children and adolescents worldwide are diagnosed with cancer, with around 300-350 cases in Austria. International Childhood Cancer Day on February 15 draws attention to the special medical, psychological, and social challenges faced by affected children

International Childhood Cancer Day: Research as the key to better survival rates Read More »

Attendees of the 2026 St. Anna CCRI Symposium

St. Anna CCRI Symposium 2026: Bridging Developmental Biology and Childhood Cancer Research 

St. Anna CCRI Symposium 2026: Bridging Developmental Biology and Childhood Cancer Research Last Friday, we hosted the second edition of the St. Anna CCRI Symposium. Organized by Principal Investigators Davide Seruggia, Polina Kameneva, and Florian Halbritter, this year’s symposium focused on Cell Fate in Cancer and Development.  Childhood cancer often stems from developmental errors that cause cells to get stuck

St. Anna CCRI Symposium 2026: Bridging Developmental Biology and Childhood Cancer Research  Read More »

Stop through SPOP: Strategy Against Aggressive Blood Cancer

Stop through SPOP: Vienna-based Researchers Develop Strategy Against Aggressive Blood Cancer (Vienna, November 2025) Acute myeloid leukemia (AML) with NUP98 fusions (NUP98-r) is an aggressive form of blood cancer. It is caused by a chromosomal rearrangement that abnormally fuses the NUP98 gene with other genes, resulting in the formation of NUP98 fusion oncoproteins. Until now,

Stop through SPOP: Strategy Against Aggressive Blood Cancer Read More »

How immune cells deliver their deadly cargo

How immune cells deliver their deadly cargo When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the release of toxic granules – microscopic packages that destroy virus-infected or cancerous cells. The study led by researchers from CeMM, St. Anna CCRI, MedUni Vienna, Med Uni Graz, the University

How immune cells deliver their deadly cargo Read More »

IGF-1 as the “Ignition Key” for Bone Cancer: Vienna-Based Research Team Unravels Origins of Ewing Sarcoma

IGF-1 as the “Ignition Key” for Bone Cancer: Vienna-Based Research Team Unravels Origins of Ewing Sarcoma A team of scientists led by Heinrich Kovar, Principal Investigator at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) in Vienna, has uncovered a key mechanism in the development of Ewing sarcoma, one of the most aggressive forms

IGF-1 as the “Ignition Key” for Bone Cancer: Vienna-Based Research Team Unravels Origins of Ewing Sarcoma Read More »

Long Night of Research 2024 – An Evening of Innovation and Collaboration in Pediatric Cancer Research

Long Night of Research 2024 – An Evening of Innovation and Collaboration in Pediatric Cancer Research The Long Night of Research 2024 was a great success, and we are thrilled with the high turnout of visitors. Under the theme “Innovation through Collaboration,” we were able to introduce numerous interested individuals to the fascinating world of

Long Night of Research 2024 – An Evening of Innovation and Collaboration in Pediatric Cancer Research Read More »

EuSARC 2023 in Vienna: Bringing together sarcoma researchers from across the world

EuSARC 2023 in Vienna: Bringing together sarcoma researchers from across the world (Vienna, 25.5.2023) St. Anna Children’s Cancer Research Institute is happy to have hosted this year’s EuSARC conference in Vienna covering multi-disciplinary topics from molecular mechanisms to novel therapies in sarcomas! Thanks to all the great speakers and attendees! “We are very excited to see

EuSARC 2023 in Vienna: Bringing together sarcoma researchers from across the world Read More »

Innovative Therapies for Children with Cancer: ITCC Conference for the first time in Vienna

Innovative Therapies for Children with Cancer: ITCC Conference for the first time in Vienna (Vienna, May 23, 2023) On May 25th, the first two-day conference of the consortium for “Innovative Therapies for Children with Cancer in Europe” (ITCC) will start in Vienna. St. Anna Children’s Cancer Research Institute, St. Anna Children’s Hospital, and the Pediatric Neuro-Oncology

Innovative Therapies for Children with Cancer: ITCC Conference for the first time in Vienna Read More »

International sarcoma meeting “EuSARC” hosted by St. Anna CCRI in Vienna

From May 18th to 20th, St. Anna Children’s Cancer Research Institute (St. Anna CCRI) welcomes scientists and physicians from Europe, the USA, and beyond, at the EuSARC 2023 meeting in Vienna. EuSARC is a Europe-wide group of scientists holding annual meetings to address the dire need for novel therapies in sarcomas, a group of poorly explored bone and soft tissue tumors.

International sarcoma meeting “EuSARC” hosted by St. Anna CCRI in Vienna Read More »

Evolution 2.0: What makes cancer more malignant

Evolution 2.0: What makes cancer more malignant (Vienna, 23.09.2022) Congratulations! A paper has just been published in the top journal Nature Genetics, with the participation of Dr. Sabine Taschner-Mandl and Dr. Marie Bernkopf from St. Anna CCRI. The authors of this outstanding paper show that random inheritance patterns of cancer genes outside the chromosome, i.e. the scaffold

Evolution 2.0: What makes cancer more malignant Read More »